In a report released today, Saket Kalia from Barclays maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of ...

Truist Financial analyst Jailendra Singh reiterated a Hold rating on Veeva Systems (VEEV – Research Report) today and set a price target of $217.00. See what stocks are receiving Strong Buy ...

Veeva Systems published its Q4 report yesterday, and the stock is rising thanks to strong results. In addition to sales and earnings that beat Wall Street's targets, Veeva's earnings guidance was ...

Veeva reported fourth-quarter revenue of $720.9 million, up 14% year-over-year. The company's revenue and earnings per share beat analyst estimates for the quarter. Feel unsure about the market ...

Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases "Together with Veeva, Boehringer has advanced its approach to clinical ...

But there’s a powerful fundamental story happening with Veeva. Also, EPS is estimated to ramp higher this year by +10.9%. Now it makes sense why the stock has been powering to new heights.

Shares of Veeva Systems (NYSE: VEEV) are posting big gains in Thursday's trading despite broader sell-offs for the tech sector. The life-sciences software company's stock was up 10.2% as of 12:30 ...

Healthcare software provider Veeva Systems (NASDAQ:VEEV) reported Q4 CY2024 results exceeding the market’s revenue expectations , with sales up 14.3% year on year to $720.9 million. The company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...